{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
\red170\green170\blue170;
\red85\green85\blue85;
\red37\green37\blue37;
\red33\green33\blue33;
\red119\green119\blue119;
\red80\green80\blue80;
\red51\green51\blue51;
\red56\green124\blue43;
\red14\green86\blue140;
\red151\green151\blue151;
\red238\green238\blue238;
\red20\green93\blue164;
\red246\green246\blue246;
\red255\green248\blue96;
\red204\green204\blue204;
\red254\green254\blue0;
\red21\green137\blue21;
\red0\green114\blue54;
\red106\green144\blue39;
\red107\green107\blue106;
\red203\green203\blue203;
\red245\green245\blue245;
\red232\green233\blue232;
\red249\green249\blue249;
\red214\green214\blue214;
\red247\green247\blue247;
\red181\green79\blue104;
\red255\green255\blue102;
\red61\green61\blue61;
\red187\green187\blue187;
\red239\green122\blue2;
\red255\green255\blue174;
\red228\green231\blue232;
\red240\green240\blue240;
\red233\green233\blue233;
\red255\green255\blue204;
\red255\green204\blue0;
\red249\green250\blue251;
\red105\green105\blue105;
\red227\green227\blue227;
\red102\green0\blue102;
\red112\green112\blue112;
\red118\green118\blue118;
\red183\green242\blue206;
\red172\green172\blue172;
\red9\green56\blue84;
\red236\green236\blue236;
\red68\green68\blue68;
\red214\green9\blue9;
\red240\green248\blue255;
\red127\green127\blue127;
\red229\green243\blue255;
\red179\green218\blue255;
\red188\green41\blue30;
\red190\green237\blue228;
\red120\green162\blue47;
\red251\green252\blue255;
\red72\green72\blue72;
\red190\green195\blue204;
\red208\green208\blue208;
\red153\green153\blue153;
\red71\green120\blue194;
\red153\green255\blue102;
\red182\green231\blue243;
\red221\green195\blue236;
\red204\green255\blue255;
\red190\green190\blue252;
\red223\green223\blue223;
\red239\green239\blue239;
\red255\green255\blue198;
\red220\green220\blue220;
\red255\green210\blue183;
\red255\green194\blue211;
\red86\green86\blue86;
\red250\green250\blue250;
\red70\green70\blue70;
\red218\green218\blue218;
\red214\green78\blue69;
\red61\green61\blue60;
\red250\green222\blue100;
\red186\green186\blue186;
\red255\green204\blue153;
\red23\green94\blue146;
\red227\green232\blue250;
\red70\green70\blue68;
\red242\green242\blue242;
\red102\green102\blue102;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 georgia;}{
\f4 sans-serif;}{
\f5 Source Sans Pro;}{
\f6 serif;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj 
{\*\listtable
{\list\listtemplateid-1780975102\listsimple{\listlevel\leveljc\levelfollow0\levelspace0\levelindent0{\leveltext\'01\u160\'3f}{\levelnumbers}}{\listname ;}\listid652948940}
}
{\*\listoverridetable
{\*\listoverride{\listid652948940\listoverridecount0\ls1}}
}
\paperw12240 \paperh15840 \margt1080 \margb1080 \margl1080 \margr1080 \headery720 \footery720 \itap0 \cols2 
\sectd {\header {
{\trowd \ltrrow \trleft0 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrl \trql \clvertalb \clwWidth9380 \cellx9380 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrr \trql \clwWidth700 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
{\b1 \cf18 \f0 \i0 \fs18 
{\b1 \cf18 \f0 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Natural Alternatives International, Inc. v. Allmax Nutrition, Inc., 258 F.Supp.3d 1170 (2017)
}
}
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
}\b0 \cf1 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs18 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 
}\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
}\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 \intbl \cell \row }}\par }{\footer {
{\trowd \lastrow \trleft0 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrl \trql \clvertalb \clwWidth9300 \cellx9300 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrr \trql \clwWidth700 \cellx10000 
\intbl 
{\b0 \cf17 \f0 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 
}
{\*\shppict {\pict \pngblip \picw78 \pich10 \picwgoal1170 \pichgoal150 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}}
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
}
}\b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs20 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf17 \f0 \ri0 \i0 \fs20 \li0 
{\b0 \i0 \ul0 \fs20 \f0 \chpgn }
}\qr \b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \fs20 \li0 \intbl \cell \row }}\par }
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_document_99}{\*\bkmkend co_document_99}
{\b0 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart Ieaecbd305b0f11e7bcf2cc0f37ee205d_Target}{\*\bkmkend Ieaecbd305b0f11e7bcf2cc0f37ee205d_Target}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs16 \li0 
{\*\bkmkstart co_readingModeKC_99}{\*\bkmkend co_readingModeKC_99}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs16 \li0 
{\*\bkmkstart co_readingModeCitatorFlag_99}{\*\bkmkend co_readingModeCitatorFlag_99}
{\b0 \cf1 \f2 \i0 \fs16 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/RelatedInformation/Flag?documentGuid=Ieaecbd305b0f11e7bcf2cc0f37ee205d&transitionType=Document&originationContext=docHeaderFlag&Rank=0&rs=cblt1.0&vr=3.0&contextData=(sc.Search)" }{\fldrslt 
{\*\shppict {\pict \pngblip \picw16 \pich16 \picwgoal255 \pichgoal255 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}}}}
{\b0 \cf1 \f2 \i0 \fs16 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
KeyCite Yellow Flag - Negative Treatment
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs16 \li0 
{\*\bkmkstart co_readingModeNegativeTreatment_99}{\*\bkmkend co_readingModeNegativeTreatment_99}
{\b0 \cf1 \f2 \i0 \fs16 {\fi-360 \li {\*\pn \pnlvlblt \ilvl0 \ls1 \pnindent0 \pnf1 {\f2 \pntxtb \u160\'3f}}{\listtext \b0 \cf1 \f2 \ri0 \i0 \qj \fs16 \li0 \u160\'3f\tab }\ls1 {\pntext }
{\pard }\b0 \cf1 \f2 \ri0 \i0 \qj \fs16 \li0 
{\b0 \cf1 \f2 \i0 \fs16 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
Distinguished by 
}
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Document/I8cadbb40cef711e8ae6bb4b0ae8dca5a/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DI8cadbb40cef711e8ae6bb4b0ae8dca5a%26ss%3D2041948211%26ds%3D2045723907%26origDocGuid%3DIeaecbd305b0f11e7bcf2cc0f37ee205d&listSource=RelatedInfo&list=NegativeCitingReferences&rank=0&ppcid=ced221d2a0324f678170406ec60f3af5&originationContext=docHeader&transitionType=NegativeTreatment&contextData=%28sc.Search%29&VR=3.0&RS=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
Global Apogee v. Sugarfina, Inc.
}
{\b0 \cf25 \f2 \i0 \fs16 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
, 
}
}}}
{\b0 \cf1 \f2 \i0 \fs16 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
C.D.Cal., 
}
}
{\b0 \cf1 \f2 \i0 \fs16 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
October 10, 2018
\par {\pntext }
}
}
}
}
}
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
258 F.Supp.3d 1170
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
United States District Court, S.D. California.
\par 
}
}
}
{\b0 \qc \cf19 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf19 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf19 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf19 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb240 
NATURAL ALTERNATIVES INTERNATIONAL, INC., Plaintiff,
\par 
}
}
{\b0 \qc \cf19 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf19 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
v.
\par 
}
}
{\b0 \qc \cf19 \f3 \ri120 \i0 \fs24 \li120 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Search/Results.html?query=advanced%3a+OAID(5037142490)&saveJuris=False&contentType=BUSINESS-INVESTIGATOR&startIndex=1&contextData=(sc.Default)&categoryPageUrl=Home%2fCompanyInvestigator&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem" }{\fldrslt 
{\b0 \cf25 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
ALLMAX NUTRITION, INC.
}}}
{\b0 \cf19 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
; HBS International Corp.; and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Search/Results.html?query=advanced%3a+WCAID(I406E5C3541EA11DDAD6B0014224D2780)&saveJuris=False&contentType=BUSINESS-INVESTIGATOR&startIndex=1&contextData=(sc.Default)&categoryPageUrl=Home%2fCompanyInvestigator&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem" }{\fldrslt 
{\b0 \cf25 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
Does 1\u8211\'3f100
}}}
{\b0 \cf19 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb0 
, Defendants.
\par 
}
}
}
}
{\b0 \qc \cf1 \f2 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Case No.: 16\u8211\'3fcv\u8211\'3f01764\u8211\'3fH\u8211\'3fAGS
\par 
}
}
}
{\b0 \cf1 \f3 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
|
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
Signed 06/26/2017
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf20 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_synopsis_99}{\*\bkmkend co_synopsis_99}
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
Synopsis
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Background:
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patentee whose patents pertained to beta-alanine human nutritional supplements brought action against alleged infringers, alleging, inter alia, violation of the Lanham Act and patent infringement. One alleged infringer moved for judgment on pleadings, the other alleged infringer moved for dismissal for failure to state a claim, and patentee moved for judgment on the pleadings as to alleged infringer\rquote s counterclaim.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Holdings:
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The District Court, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0136901901&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Marilyn L. Huff
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
, J., held that:
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
license agreement did not preclude licensee\rquote s challenge to validity of licensed patents;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patentee failed to state a claim of trademark infringement under the Lanham Act;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent claiming a human dietary supplement containing beta-alanine in a unit dosage of 0.4 to 16 grams was directed to natural phenomena and was invalid;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent claiming human dietary supplement containing a mixture of beta-alanine, creatine, and a carbohydrate was directed to natural phenomena and was invalid;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent claiming human dietary supplement containing a mixture of beta-alanine and glycine was directed to natural phenomena and was invalid; and
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
patent claiming a method of regulating hydronium ion concentrations in human tissue was directed to natural phenomena and was invalid.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Ordered accordingly.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b1 \cf20 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_attorneysAndLawFirms_99}{\*\bkmkend co_attorneysAndLawFirms_99}
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Attorneys and Law Firms
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1174_99}{\*\bkmkend co_pp_sp_7903_1174_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1174
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0422814001&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Caroline C. Maxwell
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Porzio, Bromberg and Newman, PC, Wahington, DC, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0133571001&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Frederick William Kosmo, Jr.
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0344726201&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Hubert Kim
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Wilson Petty Kosmo and Turner, San Diego, CA, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0329003301&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kevin M. Bell
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0126971001&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Richard J. Oparil
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0334411101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Scott A.M. Chambers
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0359062101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
William John McKeague
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Porzio Bromberg & Newman, P.C., Washington, DC, for Plaintiff.
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0220932201&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Ragesh K. Tangri
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0506395301&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Michael Aaron Feldman
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0362008301&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Sonal N. Mehta
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, Durie Tangri LLP, San Francisco, CA, for Defendants.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf20 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_opinion_99}{\*\bkmkend co_opinion_99}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icd650422c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icd650422c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdc636f1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdc636f1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdc636f1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdc636f1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb800 
ORDER:
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdc636f1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdc636f1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
(1) GRANTING DEFENDANT ALLMAX\rquote S MOTION FOR JUDGMENT ON THE PLEADINGS AND DEFENDANT HBS\rquote S MOTION TO DISMISS WITH PARTIAL LEAVE TO AMEND; AND
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdc636f1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdc636f1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
(2) DENYING PLAINTIFF\rquote S MOTION FOR JUDGMENT ON THE PLEADINGS
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0136901901&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
MARILYN L. HUFF
}}}
\sa200 
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
, District Judge
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On April 25, 2017, Defendant Allmax Nutrition, Inc. filed a motion for judgment on the pleadings pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and Defendant HBS International Corp. filed a motion to dismiss Plaintiff Natural Alternatives International, Inc.\rquote s first amended complaint pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Doc. Nos. 43, 44.) On May 19, 2017, Plaintiff filed an opposition to Defendants\rquote  motions. (Doc. No. 56.) On June 2, 2017, Defendants filed a reply. (Doc. No. 59.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On May 22, 2017, Plaintiff NAI filed a motion for judgment on the pleadings pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Doc. No. 57.) On June 12, 2017, Defendants filed an opposition to Plaintiff\rquote s motion. (Doc. No. 61.) On June 19, 2017, Plaintiff filed its reply. (Doc. No. 62.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court held a hearing on the matters on June 26, 2017. Richard J. Oparil, William J. McKeague, and Frederick W. Kosmo appeared for Plaintiff NAI. Ragesh K. Tangri appeared for Defendants Allmax and HBS. For the reasons below, the Court denies Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion, and the Court grants Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motions with partial leave to amend.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdcc0351c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdcc0351c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Background
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The following facts are taken from the allegations in Plaintiff\rquote s first amended complaint. Plaintiff NAI is a formulator, manufacturer, marketer, and supplier of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Ife6b13eb6c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
nutritional supplements
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Doc. No. 11, FAC \u182\'3f 11.) Plaintiff sells its branded CarnoSyn\u174\'3f beta-alanine product to customers throughout the United States and in other countries. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 1.) Plaintiff alleges that its CarnoSyn\u174\'3f product is covered by a robust portfolio of trademark, copyright, and patent rights. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff alleges that Defendants Allmax and HBS International Corp. offer to sell and sell dietary supplements containing beta-alanine in the United States, including through retailers located in California. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 1, 8\u8211\'3f9, 27\u8211\'3f31.) Plaintiff further alleges that Defendants\rquote  website utilizes Plaintiff\rquote s trademarks and copyrights in the marketing of Defendants\rquote  beta-alanine products. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 31\u8211\'3f55.) Plaintiff alleges that these acts constitute trademark, copyright, and patent infringement. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f\u182\'3f 77\u8211\'3f95.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On July 8, 2016, Plaintiff filed a complaint against Defendant Allmax, alleging claims for: (1) violation of the Lanham Act \u167\'3f 32; (2) copyright infringement; and (3) patent infringement. (Doc. No 1.) On October 13, 2016, Defendant Allmax filed a motion to dismiss Plaintiff\rquote s complaint for lack of personal jurisdiction. (Doc. No. 9.) In response to Allmax\rquote s motion to dismiss, 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1175_99}{\*\bkmkend co_pp_sp_7903_1175_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1175
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on October 19, 2016, Plaintiff filed a first amended complaint adding HBS as an additional defendant and alleging the same causes of action as in the original complaint and adding a claim for civil conspiracy. (Doc. No. 11.) In light of Plaintiff\rquote s first amended complaint, on October 20, 2016, the Court denied Defendant Allmax\rquote s motion to dismiss Plaintiff\rquote s original complaint as moot. (Doc. No. 13.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On November 16, 2017, Defendant Allmax filed a motion to dismiss Plaintiff\rquote s first amended complaint for lack of personal jurisdiction. (Doc. No. 18.) On February 21, 2017, the Court denied Allmax\rquote s motion to dismiss for lack of personal jurisdiction. (Doc. No. 32.) On March 14, 2017, Defendant Allmax filed counterclaims and an answer to Plaintiff\rquote s first amended complaint. (Doc. No. 33.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
By the present motions, Defendant Allmax moves for judgment on the pleadings pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and Defendant HBS moves for dismissal pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as to Plaintiff\rquote s claims for violation of Lanham Act \u167\'3f 32, patent infringement, and civil conspiracy.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00012041948211_ID0EKRBG_99}{\*\bkmkend co_fnRef_B00012041948211_ID0EKRBG_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00012041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
1
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. Nos. 43\u8211\'3f1 at 1, 44\u8211\'3f1 at 1.) In addition, Plaintiff moves for judgment on the pleadings pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as to Defendant Allmax\rquote s fourth affirmative defense and second counterclaim raising invalidity of the patents-in-suit. (Doc. No. 57\u8211\'3f1 at 2.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdd6b1b1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdd6b1b1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Discussion
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icdd6b1b1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icdd6b1b1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
I. Legal Standards for a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(b)(6)
}}}
\sb200 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Motion to Dismiss and a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
\sb200 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
 Motion for Judgment on the Pleadings
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B12041948211_99}{\*\bkmkend co_anchor_B12041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B22041948211_99}{\*\bkmkend co_anchor_B22041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B32041948211_99}{\*\bkmkend co_anchor_B32041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In patent cases, a motion to dismiss pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and a motion for judgment on the pleadings pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 are both governed by the applicable law of the regional circuit. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030374254&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1282&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1282" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
K\u8211\'3fTech Telecommunications, Inc. v. Time Warner Cable, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 714 F.3d 1277, 1282 (Fed. Cir. 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040226409&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1293&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1293" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Amdocs (Israel) Ltd. v. Openet Telecom, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 841 F.3d 1288, 1293 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR8&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 8(a)(2)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 requires that a pleading stating a claim for relief containing \u8220\'3fa short and plain statement of the claim showing that the pleader is entitled to relief.\u8221\'3f The function of this pleading requirement is to \u8220\'3fgive the defendant fair notice of what the ... claim is and the grounds upon which it rests.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2012293296&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_555&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_555" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Bell Atl. Corp. v. Twombly
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 550 U.S. 544, 555, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. A motion to dismiss under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 tests the legal sufficiency of the pleadings and allows a court to dismiss a complaint if the plaintiff has failed to state a claim upon which relief can be granted. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2025759257&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1241&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1241" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Conservation Force v. Salazar
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 646 F.3d 1240, 1241 (9th Cir. 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 provides\u8220\'3f[a]fter the pleadings are closed\u8212\'3fbut early enough not to delay trial\u8212\'3fa party may move for judgment on the pleadings.\u8221\'3f The Ninth Circuit has explained that the standard for deciding a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion \u8220\'3fis \u8216\'3ffunctionally identical\u8217\'3f \u8221\'3f to the standard for deciding a motion to dismiss under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024859050&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1055&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1055" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Cafasso, U.S. ex rel. v. Gen. Dynamics C4 Sys., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 637 F.3d 1047, 1055 n.4 (9th Cir. 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1989014572&pubNum=0000350&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_350_1192&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_350_1192" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Dworkin v. Hustler Magazine Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 867 F.2d 1188, 1192 (9th Cir. 1989)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
); 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
accord
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027938883&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1108&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1108" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Chavez v. United States
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 683 F.3d 1102, 1108 (9th Cir. 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1176_99}{\*\bkmkend co_pp_sp_7903_1176_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1176
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 A complaint will survive a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion to dismiss if it contains \u8220\'3fenough facts to state a claim to relief that is plausible on its face.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2012293296&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_570&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_570" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Bell Atl. Corp. v. Twombly
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fA claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018848474&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_678&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_678" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ashcroft v. Iqbal
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fA pleading that offers \u8216\'3flabels and conclusions\u8217\'3f or \u8216\'3fa formulaic recitation of the elements of a cause of action will not do.\u8217\'3f \u8221\'3f 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018848474&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2012293296&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_555&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_555" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Twombly
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 550 U.S. at 555, 127 S.Ct. 1955
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fNor does a complaint suffice if it tenders \u8216\'3fnaked assertion[s]\u8217\'3f devoid of \u8216\'3ffurther factual enhancement.\u8217\'3f \u8221\'3f 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018848474&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2012293296&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_557&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_557" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Twombly
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 550 U.S. at 557, 127 S.Ct. 1955
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Accordingly, dismissal for failure to state a claim is proper where the claim \u8220\'3flacks a cognizable legal theory or sufficient facts to support a cognizable legal theory.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2015647475&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1104&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1104" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mendiondo v. Centinela Hosp. Med. Ctr.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 521 F.3d 1097, 1104 (9th Cir. 2008)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In reviewing a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion to dismiss, a district court must accept as true all facts alleged in the complaint, and draw all reasonable inferences in favor of the plaintiff. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034359897&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_945&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_945" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Retail Prop. Trust v. United Bhd. of Carpenters & Joiners of Am.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 768 F.3d 938, 945 (9th Cir. 2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. But, a court need not accept \u8220\'3flegal conclusions\u8221\'3f as true. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018848474&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_678&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_678" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ashcroft v. Iqbal
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Further, it is improper for a court to assume the plaintiff \u8220\'3fcan prove facts which it has not alleged or that the defendants have violated the ... laws in ways that have not been alleged.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1983109206&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_526&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_526" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Associated Gen. Contractors of Cal., Inc. v. Cal. State Council of Carpenters
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 459 U.S. 519, 526, 103 S.Ct. 897, 74 L.Ed.2d 723 (1983)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icde30dc1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icde30dc1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Icde30dc1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Icde30dc1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
II. Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
 Motion for Judgment on the Pleadings
}
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00022041948211_ID0ESCAI_99}{\*\bkmkend co_fnRef_B00022041948211_ID0ESCAI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00022041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
2
}}}
\sb200 
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B42041948211_99}{\*\bkmkend co_anchor_B42041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In its answer, Defendant Allmax alleges as its fourth affirmative defense and second counterclaim that each and every asserted claim from the patents-in-suit is invalid. (Doc. No. 33 at 31, 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.) Plaintiff moves for judgment on the pleadings as to Allmax\rquote s invalidity affirmative defense and counterclaim. (Doc. No. 57\u8211\'3f1 at 2.) Specifically, Plaintiff argues that Allmax may not assert this affirmative defense and counterclaim because the Defendants are parties to two license agreements with Plaintiff that contain provisions prohibiting Defendants from contesting the validity of Plaintiff\rquote s patents. (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 4\u8211\'3f5.) In response, Defendants argue that the no-contest provisions contained in the license agreements are void as against public policy. (Doc. No. 61 at 3\u8211\'3f6.) In reply, Plaintiff argues that the no-contest provisions are valid and enforceable. (Doc. No. 62 at 2\u8211\'3f7.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The parties agree that they have entered into two license agreements, one in 2014 and one in 2016.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00032041948211_ID0EQFAI_99}{\*\bkmkend co_fnRef_B00032041948211_ID0EQFAI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00032041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
3
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 57\u8211\'3f1 at 2; Doc. No. 61 at 2; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Doc. No. 57\u8211\'3f3, Oparil Decl. Ex. A.) The 2014 agreement contains 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1177_99}{\*\bkmkend co_pp_sp_7903_1177_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1177
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 a provision stating: \u8220\'3f[Defendants] will not contest or aid others in contesting the validity, enforceability or NAI\rquote s ownership of and/or rights in the Patent Rights and Trademark Rights.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00042041948211_ID0EJGAI_99}{\*\bkmkend co_fnRef_B00042041948211_ID0EJGAI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00042041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
4
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 57\u8211\'3f3, Oparil Decl. Ex. A at Ex. 1 \u182\'3f 6.) The 2016 agreement similarly contains a provision stating: \u8220\'3f[Defendants] will not contest or aid others in contesting the validity, enforceability or NAI\rquote s ownership of and/or rights in the Patent Rights and Trademark Rights.\u8221\'3f (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at Ex. 2 \u182\'3f 5.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B52041948211_99}{\*\bkmkend co_anchor_B52041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B62041948211_99}{\*\bkmkend co_anchor_B62041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Circuit law governs the determination of whether an agreement bars a party from challenging the validity of a patent. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload Energy, Inc. v. Roberts
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 619 F.3d 1357, 1361 (Fed. Cir. 2010)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001114153&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1365&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1365" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Flex\u8211\'3fFoot, Inc. v. CRP, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 238 F.3d 1362, 1365 (Fed. Cir. 2001)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fIn 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear, Inc. v. Adkins
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 395 U.S. 653, 89 S.Ct. 1902, 23 L.Ed.2d 610 (1969)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Supreme Court eliminated the doctrine of \u8216\'3flicensee estoppel,\u8217\'3f citing the \u8216\'3fimportant public interest in permitting full and free competition in the use of ideas.\u8217\'3f Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 a licensee of a patent is not estopped from challenging the validity of the licensed patent by virtue of the license agreement.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 619 F.3d at 1361
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Nevertheless, the Federal Circuit subsequently has held that certain \u8220\'3fconsent decrees and settlement agreements may at one and the same time provide for a patent license while barring challenges to patent invalidity and unenforceability\u8221\'3f and that 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 does not render such agreements void. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 619 F.3d at 1361
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001114153&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1370&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1370" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Flex\u8211\'3fFoot
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 238 F.3d at 1370
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff argues that the 2016 agreement between the parties qualifies for the Federal Circuit\rquote s settlement agreement exception to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 62 at 4\u8211\'3f7.) Defendants argue that the 2016 agreement is unenforceable under 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 because only a post-litigation settlement can qualify for the Federal Circuit\rquote s exception to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 61 at 5 n.1) The Court agrees with Defendants.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028171756&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_167&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_167" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Rates Tech. Inc. v. Speakeasy, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 685 F.3d 163, 167\u8211\'3f74 (2d Cir. 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Second Circuit engaged in an extensive analysis of Supreme Court and Federal Circuit case law on this issue and held that a no-contest clause contained in a pre-litigation settlement agreement is unenforceable under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 regardless of whether the agreement is styled as a settlement agreement or a license agreement. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028171756&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_172" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 172
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041873501&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo, LLC v. PatentRatings, LLC
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. 12 C 8450, 2017 WL 2588430, at *9 (N.D. Ill. June 14, 2017)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (holding same). The Court acknowledges that Federal Circuit law, not Second Circuit law, governs the determination of whether an agreement bars a party from challenging the validity of a patent. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 619 F.3d at 1361
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001114153&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1365&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1365" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Flex\u8211\'3fFoot
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 238 F.3d at 1365
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Nevertheless, the Court finds the Second Circuit\rquote s decision in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028171756&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Rates Tech.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 well-reasoned and persuasive and, therefore, the Court will apply its holding to the present case.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff asserts that a no-contest clause in a pre-litigation settlement agreement can be enforceable if the clause contains clear and unambiguous language barring the licensee\rquote s ability to challenge a patent\rquote s 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1178_99}{\*\bkmkend co_pp_sp_7903_1178_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1178
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 validity. (Doc. No. 62 at 3.) In making this assertion, Plaintiff relies on the Federal Circuit\rquote s decision in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and the district court decision 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2037261360&pubNum=0007903&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_7903_1119&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_1119" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo, LLC v. Barney
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 133 F.Supp.3d 1107, 1119 (N.D. Ill. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Court does not find Plaintiff\rquote s reliance on these two cases persuasive.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
First, in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit never held that a no-contest clause in a pre-litigation settlement agreement can be enforceable. In 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit was faced with a situation where the parties had entered into a settlement agreement containing a no-contest clause following prior litigation between the parties, but the validity of the relevant patent was not at issue during that prior litigation. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1359&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1359" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
619 F.3d at 1359\u8211\'3f60
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In analyzing the issues in that case, the Federal Circuit explained that \u8220\'3f[i]n the context of settlement agreements, as with consent decrees, clear and unambiguous language barring the right to challenge patent validity in future infringement actions is sufficient, even if invalidity claims had not been previously at issue and had not been actually litigated.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1363&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1363" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1363
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Here, the Federal Circuit merely stated that in order for a no-contest clause in a litigation-settlement agreement to be enforceable, the validity of the patent-in-suit need not have been actually litigated by the parties in the prior litigation. The 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 decision says nothing about the situation where there was no litigation at all between the parties at the time they entered into the relevant agreement. In addition, the Court notes that in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Baseload
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit ultimately declined to enforce the no-contest clause at issue. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1358&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1358" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1358, 1363\u8211\'3f64
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Second, although the district court in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2037261360&pubNum=0007903&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 initially held that a no-contest clause in a pre-litigation settlement agreement can be enforceable, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2037261360&pubNum=0007903&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_7903_1121&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_1121" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 133 F.Supp.3d at 1121
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, that district court subsequently revisited that holding and later held, instead, that a no-challenge clause \u8220\'3fas a provision in a pre-litigation agreement ... is not enforceable.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041873501&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 2017 WL 2588430, at *9
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In sum, the Court agrees with the Second Circuit\rquote s analysis in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028171756&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Rates Tech.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and holds that a no-contest clause contained in a pre-litigation settlement agreement is unenforceable under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}}}
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Here, Defendants assert that the relevant agreements were entered into prior to any litigation between the parties. (Doc. No. 61 at 5 n.1.) Plaintiff does not contest this assertion and concedes that the \u8220\'3fthe 2016 Agreement was a pre-suit settlement.\u8221\'3f (Doc. No. 62 at 6.) Indeed, the Court notes that Plaintiff states that the 2016 agreement was executed on June 7, 2016, (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 5), but the present action was not filed until July 8, 2016. (Doc. No. 1.) Thus, both the 2014 agreement and the 2016 agreement are pre-litigation settlement agreements and, therefore, the no-contest provisions in those agreements are unenforceable under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1969133016&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Lear
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}}}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00052041948211_ID0EH1AI_99}{\*\bkmkend co_fnRef_B00052041948211_ID0EH1AI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00052041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
5
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028171756&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_172" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Rates Tech.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 685 F.3d at 172
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041873501&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ocean Tomo
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 2017 WL 2588430, at *9
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Because the no-contest clauses contained in the relevant agreements are unenforceable, Plaintiff is not entitled to judgment on the pleadings as to Defendant Allmax\rquote s invalidity affirmative defense and counterclaim. Accordingly, the Court denies Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion for judgment 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1179_99}{\*\bkmkend co_pp_sp_7903_1179_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1179
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on the pleadings.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00062041948211_ID0EM4AI_99}{\*\bkmkend co_fnRef_B00062041948211_ID0EM4AI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00062041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
6
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice016b31c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice016b31c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice016b31c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice016b31c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
III. Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12
}}}
\sb200 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
 Motions
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice016b31c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice016b31c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
A. Plaintiff\rquote s Lahnam Act Claim
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B72041948211_99}{\*\bkmkend co_anchor_B72041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In the FAC, Plaintiff alleges a claim against Defendants for violation of Lanham Act \u167\'3f 32. (Doc. No. 11, FAC \u182\'3f\u182\'3f 56\u8211\'3f57, 77\u8211\'3f83.) Defendants argue that this claim should be dismissed because Plaintiff has failed to adequately allege that Defendants are using Plaintiff\rquote s trademark in conjunction with the sale of unauthorized products. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(Doc. No. 43\u8211\'3f1 at 5\u8211\'3f8; Doc. No. 44\u8211\'3f1 at 5\u8211\'3f8.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B82041948211_99}{\*\bkmkend co_anchor_B82041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B92041948211_99}{\*\bkmkend co_anchor_B92041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B102041948211_99}{\*\bkmkend co_anchor_B102041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
To establish a claim for trademark infringement under the Lanham Act, a plaintiff must demonstrate: \u8220\'3f(1) ownership of a valid mark (i.e., a protectable interest), and (2) that the alleged infringer\rquote s use of the mark is likely to cause confusion, or to cause mistake, or to deceive consumers.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2009514832&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1134&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1134" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Reno Air Racing Ass\rquote n, Inc. v. McCord
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 452 F.3d 1126, 1134 (9th Cir. 2006)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=15USCAS1114&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RB&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_9f800000f2221" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
15 U.S.C. \u167\'3f 1114(1)(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThe core element of trademark infringement is whether customers are likely to be confused about the source or sponsorship of the products.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2009514832&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1135&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1135" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Reno Air Racing Ass\rquote n
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 452 F.3d at 1135
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Likelihood of confusion \u8220\'3fexists \u8216\'3fwhenever consumers are likely to assume that a mark is associated with another source.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002225910&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_854&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_854" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Karl Storz Endoscopy Am., Inc. v. Surgical Techs., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 285 F.3d 848, 854 (9th Cir. 2002)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In analyzing likelihood of confusion, courts utilize the eight-factor test set forth in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1979113164&pubNum=0000350&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
AMF Inc. v. Sleekcraft Boats
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 599 F.2d 341 (9th Cir. 1979)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2037422348&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_936&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_936" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Multi Time Mach., Inc. v. Amazon.com, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 804 F.3d 930, 936 (9th Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In their motion, Defendants argue that Plaintiff\rquote s allegations as to its trademark claim are inadequate because Plaintiff fails to specifically allege in the FAC that the beta-alanine in Defendants\rquote  accused products with CarnoSyn\u174\'3f on the label came from an unauthorized source, i.e., a source other than NAI or its authorized seller Compound Solutions, Inc. (Doc. No. 59 at 3; Doc. No. 43\u8211\'3f1 at 6; Doc. No. 44\u8211\'3f1 at 6.) In response, at the hearing, Plaintiff argued that it is able to allege such conduct by Defendants and that this issue could appropriately be addressed through amendment of the allegations in the FAC. Accordingly, in light of this, the Court grants Defendants\rquote  motions and dismisses Plaintiff\rquote s trademark claim without prejudice and with leave to amend.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice075ea2c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice075ea2c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice075ea2c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice075ea2c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
B. Plaintiff\rquote s Claim for Patent Infringement
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In the FAC, Plaintiff alleges a claim against Defendants for patent infringement, alleging infringement of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 5,965,596
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,504,376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2023575930&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=Iaa8a02cbe6d811df852cd4369a8093f1&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,825,084
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. RE45,947. (Doc. No. 11, FAC \u182\'3f\u182\'3f 19\u8211\'3f26, 61\u8211\'3f70, 91\u8211\'3f95.)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants argue that the Court should dismiss Plaintiff\rquote s patent infringement claim because the patents-in-suit fail to claim patent-eligible subject matter and, therefore, are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Doc. No. 43\u8211\'3f1 at 8\u8211\'3f18; Doc. No. 44\u8211\'3f1 at 8\u8211\'3f18.) In response, Plaintiff argues that the patents-in-suit are directed to patent-eligible subject matter.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00072041948211_ID0EOHBI_99}{\*\bkmkend co_fnRef_B00072041948211_ID0EOHBI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00072041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
7
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 56 at 12\u8211\'3f23.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice0b2f33c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice0b2f33c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1180_99}{\*\bkmkend co_pp_sp_7903_1180_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1180
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
i. Legal Standards for Patent Eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B112041948211_99}{\*\bkmkend co_anchor_B112041948211_99}
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the Patent Act defines patent-eligible subject matter as \u8220\'3fany new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Supreme Court has \u8220\'3f \u8216\'3flong held that this provision contains an important implicit exception[:] Laws of nature, natural phenomena, and abstract ideas are not patentable.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2116&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2116" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. Myriad Genetics, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 569 U.S. 576, 133 S.Ct. 2107, 2116, 186 L.Ed.2d 124 (2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThe concern underlying these judicial exclusions is that \u8216\'3fpatent law not inhibit further discovery by improperly tying up the future use of these building blocks of human ingenuity.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Rapid Litig. Mgmt. Ltd. v. CellzDirect, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d 1042, 1047 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B122041948211_99}{\*\bkmkend co_anchor_B122041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fThe Supreme Court has devised a two-stage framework to determine whether a claim falls outside the scope of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
section
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039836349&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1257&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1257" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Affinity Labs of Texas, LLC v. DIRECTV, LLC
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 838 F.3d 1253, 1257 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice Corp. Pty. v. CLS Bank Int\rquote l
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2347, 2355, 189 L.Ed.2d 296 (2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThe prescribed approach requires a court to determine (1) whether the claim is directed to a patent-ineligible concept, i.e., a law of nature, a natural phenomenon, or an abstract idea, and if so, (2) whether the elements of the claim, considered both individually and as an ordered combination, add enough to transform the nature of the claim into a patent-eligible application.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039836349&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1257&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1257" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Affinity Labs
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 838 F.3d at 1257
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (internal quotation marks omitted) (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B132041948211_99}{\*\bkmkend co_anchor_B132041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B142041948211_99}{\*\bkmkend co_anchor_B142041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The first step of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry requires courts \u8220\'3fto look at the \u8216\'3ffocus of the claimed advance over the prior art\u8217\'3f to determine if the claim\rquote s \u8216\'3fcharacter as a whole\u8217\'3f is directed to excluded subject matter.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039836349&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1257&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1257" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1257
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThe [second] step requires [courts] to look with more specificity at what the claim elements add, in order to determine \u8216\'3fwhether they identify an \u8220\'3finventive concept\u8221\'3f in the application of the ineligible subject matter\u8217\'3f to which the claim is directed.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039836349&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1258&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1258" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1258
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThis inventive concept must do more than simply recite \u8216\'3fwell-understood, routine, conventional activity.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039977858&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1093&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1093" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
FairWarning IP, LLC v. Iatric Sys., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 839 F.3d 1089, 1093 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Federal Circuit has expressly recognized that \u8220\'3fit is possible and proper to determine patent eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(b)(6)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion [or a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion].\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00082041948211_ID0ERVBI_99}{\*\bkmkend co_fnRef_B00082041948211_ID0ERVBI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00082041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
8
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1373&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1373" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Genetic Techs. Ltd. v. Merial L.L.C.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 818 F.3d 1369, 1373 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040226409&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1293&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1293" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Amdocs
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 841 F.3d at 1293
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (reviewing eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an appeal from a grant of judgment on the pleadings under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
); 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039262742&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1347&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1347" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Bascom Glob. Internet Servs., Inc. v. AT & T Mobility LLC
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d 1341, 1347 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fCourts may ... dispose of patent-infringement claims under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 whenever procedurally appropriate.\u8221\'3f). Further, the Federal Circuit has explained that where there is \u8220\'3fno claim construction dispute relevant to the eligibility 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1181_99}{\*\bkmkend co_pp_sp_7903_1181_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1181
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 issue,\u8221\'3f evaluation of a patent claim\rquote s subject matter eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 can proceed before claim construction.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00092041948211_ID0EHZBI_99}{\*\bkmkend co_fnRef_B00092041948211_ID0EHZBI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00092041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
9
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1373&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1373" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Genetic Techs.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 818 F.3d at 1373
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041877586&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1360&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1360" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Cleveland Clinic Found. v. True Health Diagnostics LLC
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 859 F.3d 1352, 1360, 2017 WL 2603137, at *6 (Fed. Cir. 2017)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[W]e have repeatedly affirmed 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 rejections at the motion to dismiss stage, before claim construction or significant discovery has commenced.\u8221\'3f); 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028287013&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1273&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1273" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Bancorp Servs., L.L.C. v. Sun Life Assur. Co. of Canada (U.S.)
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 687 F.3d 1266, 1273 (Fed. Cir. 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[C]laim construction is not an inviolable prerequisite to a validity determination under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice2a4ff1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice2a4ff1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
ii. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2023575930&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=Iaa8a02cbe6d811df852cd4369a8093f1&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 Patent
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B152041948211_99}{\*\bkmkend co_anchor_B152041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2023575930&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=Iaa8a02cbe6d811df852cd4369a8093f1&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00102041948211_ID0E4ACI_99}{\*\bkmkend co_fnRef_B00102041948211_ID0E4ACI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00102041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims: \u8220\'3fA human dietary supplement, comprising a beta-alanine in a unit dosage of between about 0.4 grams to 16 grams, wherein the supplement provides a unit dosage of beta-alanine.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,925,084
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 22:26\u8211\'3f29 (filed Nov. 2, 2010). The Court begins its analysis of this claim with step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry. \u8220\'3fThe step one inquiry focuses on determining \u8216\'3fwhether the claim at issue is \u8216\'3fdirected to\u8217\'3f a judicial exception, such as an abstract idea.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040400358&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1241&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1241" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Apple, Inc. v. Ameranth, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 842 F.3d 1229, 1241 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. This inquiry requires courts \u8220\'3fto look at the \u8216\'3ffocus of the claimed advance over the prior art\u8217\'3f to determine if the claim\rquote s \u8216\'3fcharacter as a whole\u8217\'3f is directed to excluded subject matter.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039836349&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1257&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1257" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Affinity Labs
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 838 F.3d at 1257
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Here, claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims a human dietary supplement containing beta-alanine in a unit dosage of 0.4 to 16 grams. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Beta-alanine is the only ingredient of the supplement referenced in the language of claim 1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 22:26\u8211\'3f29. Thus, beta-alanine is the focus of the claim.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00112041948211_ID0E6MCI_99}{\*\bkmkend co_fnRef_B00112041948211_ID0E6MCI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00112041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
11
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In its specification, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1182_99}{\*\bkmkend co_pp_sp_7903_1182_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1182
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 explains that beta-alanine is an amino acid, 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 3:3\u8211\'3f6, and is \u8220\'3fpresent in the muscles of humans and other vertebrates.\u8221\'3f 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2:21\u8211\'3f26; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 8:49\u8211\'3f53 (\u8220\'3fThese precursors[, beta-alanine and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=bdrug&entityId=I396eb006475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
L\u8211\'3fhistidine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
], can be generated within the body or are made available via the diet.\u8221\'3f). (
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Doc. No. 11, FAC \u182\'3f 12; Doc. No. 56 at 16.) Thus, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 acknowledges that beta-alanine is a natural occurring phenomenon.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00122041948211_ID0EIPCI_99}{\*\bkmkend co_fnRef_B00122041948211_ID0EIPCI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00122041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
12
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Accordingly, claim 1 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to excluded subject matter\u8212\'3fspecifically beta-alanine, a natural phenomenon\u8212\'3fthereby satisfying step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa Diagnostics, Inc. v. Sequenom, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d 1371, 1376 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
cert. denied
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&pubNum=0000708&cite=136SCT2511&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 136 S.Ct. 2511, 195 L.Ed.2d 841 (2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (finding step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry satisfied where the claims were directed to cffDNA, a naturally occurring phenomenon).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff argues that a human dietary supplement containing beta-alanine is not a natural phenomenon, and, therefore, the claim is directed to patent-eligible subject matter. (Doc. No. 56 at 17\u8211\'3f18, 19\u8211\'3f20, 21\u8211\'3f22.) But in making this argument, Plaintiff misconstrues the step one analysis for determining subject matter eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Step one of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry does not simply look to whether the overall claimed invention is itself a natural phenomenon. Rather, step one of the inquiry requires a court to look at what the claim is specifically directed to and whether what it is directed to is a natural phenomenon, law of nature, or abstract idea. For example, a computer is a physical machine and is not itself an abstract idea. Nevertheless, in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Supreme Court found that the claims at issue were directed to an abstract idea\u8212\'3fspecifically, \u8220\'3fthe concept of intermediated settlement\u8221\'3f\u8212\'3feven though all of the claims were implemented using a computer. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2352&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2352" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
134 S.Ct. at 2352\u8211\'3f53, 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2358&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2358" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2358
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fThe fact that a computer \u8216\'3fnecessarily exist[s] in the physical, rather than purely conceptual, realm,\u8217\'3f is beside the point.\u8221\'3f). Similarly, here, claim 1 is directed to the natural phenomenon beta-alanine even though the claim is implemented using a \u8220\'3fhuman dietary supplement.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00132041948211_ID0EDZCI_99}{\*\bkmkend co_fnRef_B00132041948211_ID0EDZCI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00132041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
13
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Because claim 1 is directed to a 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1183_99}{\*\bkmkend co_pp_sp_7903_1183_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1183
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 natural phenomenon, the Court will now turn to step two of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B162041948211_99}{\*\bkmkend co_anchor_B162041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In step two, the reviewing court \u8220\'3fexamine[s] the elements of the claims to determine whether they contain an inventive concept sufficient to transform the claimed naturally occurring phenomena into a patent-eligible application.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041877586&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Cleveland Clinic
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 859 F.3d at 1361, 2017 WL 2603137, at *7
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The court \u8220\'3fmust consider the elements of the claims both individually and as an ordered combination to determine whether additional elements transform the nature of the claims into a patent-eligible concept.\u8221\'3f 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041877586&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Further, the inventive concept contained in the claim \u8220\'3fmust do more than simply recite \u8216\'3fwell-understood, routine, conventional activity.\u8217\'3f \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039977858&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1093&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1093" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
FairWarning IP, LLC v. Iatric Sys., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 839 F.3d 1089, 1093 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039891907&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1313&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1313" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Intellectual Ventures I LLC v. Symantec Corp.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 838 F.3d 1307, 1313 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f \u8216\'3f[S]imply appending conventional steps, specified at a high level of generality,\u8217\'3f which are \u8216\'3fwell known in the art\u8217\'3f and consist of \u8216\'3fwell-understood, routine, conventional activit[ies]\u8217\'3f previously engaged in by workers in the field, is not sufficient to supply the inventive concept.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Here, the inventive concept described in claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is placing a specific dosage of beta-alanine into a human dietary supplement. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 22:26\u8211\'3f29. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 acknowledges that placing a natural substance into a dietary supplement is conventional activity. The background section of the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 provides:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
Natural food supplements are typically designed to compensate for reduced levels of nutrients in the modern human and animal diet. In particular, useful supplements increase the function of tissues when consumed. It can be particularly important to supplement the diets of particular classes of animals whose normal diet may be deficient in nutrients available only from meat and animal products....
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1:37\u8211\'3f44. Because placing a natural substance into a dietary supplement is a conventional activity, employing a dietary supplement to administer the beta-alanine, a natural phenomenon, is insufficient to render claim 1 patent eligible. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1377&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1377" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1377
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (holding that utilizing routine and convention methods for amplifying and detecting cffDNA, a natural phenomenon, was insufficient to render the claims at issue patent eligible); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2357&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2357" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2357\u8211\'3f58
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (holding that the introduction of a general-purpose computer to implement an abstract idea was insufficient to render the claims at issue patent eligible); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_78&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_78" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo Collaborative Servs. v. Prometheus Labs., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 566 U.S. 66, 78\u8211\'3f82, 132 S.Ct. 1289, 182 L.Ed.2d 321 (2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (finding the steps of administering a drug and then reconsidering the dosage in light of a natural law insufficient to render the claims at issue patent eligible). Accordingly, representative claim 1 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to patent-ineligible subject matter, and, thus, is invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B172041948211_99}{\*\bkmkend co_anchor_B172041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff argues that the claimed invention of providing the amino acid beta-alanine in effective amounts to a human does not preempt the natural law of regulating hydronium ion concentration in human tissue. (Doc. No. 56 at 18\u8211\'3f19, 21\u8211\'3f22.) But the Federal Circuit has explained that \u8220\'3f[w]hile preemption may signal patent ineligible 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1184_99}{\*\bkmkend co_pp_sp_7903_1184_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1184
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 subject matter, the absence of complete preemption does not demonstrate patent eligibility.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1379&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1379" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1379
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fWhere a patent\rquote s claims are deemed only to disclose patent ineligible subject matter under the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
[/
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] framework, ... preemption concerns are fully addressed and made moot.\u8221\'3f 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
accord
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041877586&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1363&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1363" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Cleveland Clinic
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 859 F.3d at 1363, 2017 WL 2603137, at *8
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Here, under the two-step 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 framework, representative claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 only discloses patent ineligible subject matter. Thus, any potential preemption concerns are fully addressed through that analysis.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00142041948211_ID0EKIDI_99}{\*\bkmkend co_fnRef_B00142041948211_ID0EKIDI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00142041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
14
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In sum, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 084 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for claiming patent-ineligible subject matter.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice4292e1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice4292e1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
iii. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 947 Patent
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B182041948211_99}{\*\bkmkend co_anchor_B182041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 947 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A human dietary supplement for increasing human muscle tissue strength comprising a mixture of creatine, a carbohydrate and free amino acid beta-alanine that is not part of a dipeptide, polypeptide or an oligopeptide, wherein the human dietary supplement does not contain a free amino acid 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=bdrug&entityId=I396eb006475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
L-histidine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, wherein the free amino acid beta-alanine is in an amount that is from 0.4 g to 16.0 g per daily dose, wherein the amount increases the muscle tissue strength in the human, and wherein the human dietary supplement is formulated for one or more doses per day for at least 14 days.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. RE45,947
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 16:1\u8211\'3f11 (filed Mar. 29, 2016). The Court begins its analysis of this claim with step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry. Claim 34 claims a human dietary supplement containing a mixture of beta-alanine, creatine, and a carbohydrate.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00152041948211_ID0EJNDI_99}{\*\bkmkend co_fnRef_B00152041948211_ID0EJNDI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00152041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
15
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Beta-alanine is a naturally occurring phenomenon. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 947 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2:9\u8211\'3f15, 5:21\u8211\'3f25. In addition, the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 947 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 discloses that creatine is also a naturally occurring phenomenon. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1:50\u8211\'3f55 (\u8220\'3fCreatine ... is found in large amounts in skeletal muscle and other \u8216\'3fexcitable\u8217\'3f tissues (e.g., smooth muscle, cardiac muscle, or spermatozoa) ....\u8221\'3f). Further, a carbohydrate is also a naturally occurring phenomenon. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 3:33\u8211\'3f34, 5:61\u8211\'3f63, 6:57\u8211\'3f58. Thus, claim 34 is directed to excluded subject matter, specifically the natural phenomena of beta-alanine, creatine, and carbohydrates. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Accordingly, step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry is satisfied, and the Court will turn to step two.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_130" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Funk Bros. Seed Co. v. Kalo Inoculant Co.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. 127, 130\u8211\'3f31, 68 S.Ct. 440, 92 L.Ed. 588 (1948)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Supreme Court held that mixing different natural phenomena together\u8212\'3fspecifically, in that case different bacterial species\u8212\'3fis insufficient to render an invention patent eligible even though it was not previously known that the substances could be mixed together, and the combination provided certain advantages. Thus, in the present case, mixing beta-alanine, a natural phenomenon, with a carbohydrate and creatine, two other natural phenomena, and placing that mixture in a human dietary supplement, a conventional activity, is insufficient to render claim 34 patent eligible. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Accordingly representative claim 34 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 947 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1185_99}{\*\bkmkend co_pp_sp_7903_1185_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1185
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to patent-ineligible subject matter, and, thus, is invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice485f41c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice485f41c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
iv. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 Patent
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B192041948211_99}{\*\bkmkend co_anchor_B192041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is dependent from Claim 5 which is dependent from Claim 1. Those three claims provide:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
1. A composition, comprising:
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
glycine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
; and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
a) an amino acid selected from the group consisting of a beta-alanine, an ester of a beta-alanine, and an amide of a beta-alanine, or
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li400 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
b) a di-peptide selected from the group consisting of a beta-alanine di-peptide and a beta-alanylhistidine di-peptide.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
...
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
5. The composition of claim 1, wherein the composition is a dietary supplement or a sports drink.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
6. The composition of claim 5, wherein the dietary supplement or sports drink is a supplement for humans.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,504,376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 22:27\u8211\'3f47 (filed Mar. 17, 2009). The Court begins its analysis of this claim with step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry. Claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims a human dietary supplement containing a mixture of beta-alanine and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
glycine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00162041948211_ID0EDZDI_99}{\*\bkmkend co_fnRef_B00162041948211_ID0EDZDI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00162041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
16
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Beta-alanine is a naturally occurring phenomenon. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2:15\u8211\'3f20, 8:51\u8211\'3f55. In addition, the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 discloses that 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
glycine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is also a naturally occurring phenomenon.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00172041948211_ID0EM1DI_99}{\*\bkmkend co_fnRef_B00172041948211_ID0EM1DI_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00172041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
17
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1:56\u8211\'3f61, 6:1\u8211\'3f5. Thus, claim 6 is directed to excluded subject matter, specifically beta-alanine, a natural phenomenon, and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
glycine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, a natural phenomenon. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Accordingly, step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry is satisfied, and the Court will turn to step two.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Under the Supreme Court\rquote s decision in 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Funk Bros.
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, mixing beta-alanine, a natural phenomenon, with 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
glycine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, a natural phenomenon, and placing that mixture in a human dietary supplement, a conventional activity, is insufficient to render claim 6 patent eligible. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_130" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Funk Bros.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. at 130\u8211\'3f31, 68 S.Ct. 440
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Accordingly representative claim 6 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 376 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to patent-ineligible subject matter, and, thus, is invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice56b721c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice56b721c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
v. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 Patent
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B202041948211_99}{\*\bkmkend co_anchor_B202041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
A method of regulating hydronium ion concentrations in a human tissue comprising:
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1186_99}{\*\bkmkend co_pp_sp_7903_1186_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1186
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 providing an amount of beta-alanine to blood or blood plasma effective to increase beta-alanylhistidine dipeptide synthesis in the human tissue; and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
exposing the tissue to the blood or blood plasma, whereby the concentration of beta-alanylhistidine is increased in the human tissue.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 5,965,596
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 14:66\u8211\'3f15:6 (filed Oct. 12, 1999). The Court begins its analysis of this claim with step one of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry. Claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 claims a method of regulating hydronium ion concentrations in human tissue by provided the amino acid beta\u8211\'3falanine to human tissue via blood or blood plasma thereby increasing the carnosine content in the tissue. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Doc. No. 56 at 18.) The Court agrees with Defendants that this claim is directed to a law of nature, specifically the principle that ingesting beta-alanine, a natural substance, will increase carnosine concentration in tissue and, thereby, aid in regulating the hydronium ion concentration in the tissue.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00182041948211_ID0ERIAK_99}{\*\bkmkend co_fnRef_B00182041948211_ID0ERIAK_99}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00182041948211_99" }{\fldrslt 
{\super \b0 \cf25 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
18
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_77&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_77" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 566 U.S. at 77, 132 S.Ct. 1289
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (finding that claims at issue were directed to laws of nature); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1374&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1374" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Genetic Techs.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 818 F.3d at 1374\u8211\'3f76
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fThe method therefore begins and ends with a natural phenomenon.\u8221\'3f). Because claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to a law of nature, the Court will now turn to step two of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Turning to step two of the 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Alice
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry, the elements contained in claim 1 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 do not disclose an inventive concept sufficient to transform the claimed law of nature into a patent-eligible application. The Court agrees with Defendants that the language in claim 1 does nothing more than simply state the law of nature and add the words apply it to human tissue. Specifically, the language in claim 1 simply acknowledges the natural law that providing beta-alanine to human tissue will increase the carnosine concentration in the tissue and aid in regulating hydronium ion concentration, and then merely instructs to do so. This is insufficient to render the claim patent-eligible. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1377&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1377" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1377
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 made clear that transformation into a patent-eligible application requires \u8216\'3fmore than simply stat[ing] the law of nature while adding the words \u8216\'3fapply it.\u8217\'3f \u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000780&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_780_77&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_77" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 566 U.S. at 77, 132 S.Ct. 1289
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fIf a law of nature is not patentable, then neither is a process reciting a law of nature.\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff argues that claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to eligible subject matter because the claimed method increases the carnosine content in the tissue through a non-natural process. (Doc. No. 56 at 16, 18.) But Plaintiff fails to adequately explain how or why this is actually true. There is nothing in the claim language requiring that the carnosine concentration achieved by the method be at unnatural levels. Moreover, there is nothing in the claim language requiring that the beta-alanine used in the method come from non-natural sources, and, thus, the claim appears to encompass natural methods of exposing beta-alanine to human tissue and, thereby, increasing the carnosine content in the tissue.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff also states that the patents-in-suit discloses a new and useful method of increasing the amount of carnosine in muscles. (Doc. No. 56 at 16.) But even assuming this is true, this is insufficient to render the claims at issue patent eligible. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Supreme Court has explained that \u8220\'3f[g]roundbreaking, innovative, or even 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1187_99}{\*\bkmkend co_pp_sp_7903_1187_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1187
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 brilliant discovery does not by itself satisfy the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2117&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2117" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. Myriad Genetics, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 569 U.S. 576, 133 S.Ct. 2107, 2117, 186 L.Ed.2d 124 (2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1379&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1379" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1379\u8211\'3f80
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fWhile Drs. Lo and Wainscoat\rquote s discovery regarding cffDNA may have been a significant contribution to the medical field, that alone does not make it patentable.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1380&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1380" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Genetic Techs.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 818 F.3d at 1380
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[Plaintiff]\rquote s attempts to distinguish this case on the ground that the method of claim 1 is useful have no basis in case law or in logic. Claim 1 stands rejected under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as ineligible for claiming unpatentable subject matter, not for lack of utility. The method claims of 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Mayo
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ariosa
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 were apparently also useful, and also invalid.\u8221\'3f). In sum, representative claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 596 patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is directed to patent-ineligible subject matter, and, thus, is invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice61b3a1c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice61b3a1c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
vi. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
\sa200 
\sb400 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
 Conclusion
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In sum, the patents-in-suit claim ineligible subject matter and, thus, are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Accordingly, the Court grants Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motions with respect to this claim, and the Court dismisses Plaintiff\rquote s claim for patent infringement with prejudice.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice631331c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice631331c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice631331c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice631331c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
C. Plaintiff\rquote s Claim for Civil Conspiracy
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B212041948211_99}{\*\bkmkend co_anchor_B212041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In the FAC, Plaintiff alleges a claim against Defendants for civil conspiracy. (Doc. No. 11, FAC \u182\'3f\u182\'3f 96\u8211\'3f102.) Defendants argue that this claim should be dismissed because it fails to state a claim under state law. (Doc. No. 43\u8211\'3f1 at 18\u8211\'3f19; Doc. No. 44\u8211\'3f1 at 18\u8211\'3f19.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B222041948211_99}{\*\bkmkend co_anchor_B222041948211_99}
}
{\b0 \cf25 \f2 \i0 \fs20 
{\*\bkmkstart co_anchor_B232041948211_99}{\*\bkmkend co_anchor_B232041948211_99}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fUnder California law, there is no separate and distinct tort cause of action for civil conspiracy.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1997173073&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1228&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1228" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Entm\rquote t Research Grp., Inc. v. Genesis Creative Grp., Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 122 F.3d 1211, 1228 (9th Cir. 1997)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1994075364&pubNum=0004040&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_4040_510&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_4040_510" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Applied Equip. Corp. v. Litton Saudi Arabia Ltd.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 7 Cal.4th 503, 510, 28 Cal.Rptr.2d 475, 869 P.2d 454 (1994)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fConspiracy is not a cause of action.\u8221\'3f). Rather, it is \u8220\'3fa legal doctrine that imposes liability on persons who, although not actually committing a tort themselves, share with the immediate tortfeasors a common plan or design in its perpetration.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1994075364&pubNum=0004040&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_4040_510&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_4040_510" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Applied Equip. Corp. v. Litton Saudi Arabia Ltd.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 7 Cal.4th 503, 510\u8211\'3f11, 28 Cal.Rptr.2d 475, 869 P.2d 454 (1994)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Plaintiff\rquote s civil conspiracy claim must be dismissed. First, because the Court has dismissed Plaintiff\rquote s claims for trademark infringement and patent infringement, those claims cannot serve as an underlying tort for Plaintiff\rquote s civil conspiracy claim. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027851688&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_311&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_311" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Tire Eng\rquote g & Distribution, LLC v. Shandong Linglong Rubber Co.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 682 F.3d 292, 311 (4th Cir. 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fIf the underlying tort is dismissed for any reason, so, too, must the corresponding conspiracy claim be dismissed.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041761366&pubNum=0006538&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Ramos v. Ramos
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. 16-15459, 691 Fed.Appx. 487, 487\u8211\'3f88, 2017 WL 2333970, at *1 (9th Cir. May 30, 2017)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1994075364&pubNum=0004040&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_4040_511&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_4040_511" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Applied Equip. Corp.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 7 Cal.4th at 511, 28 Cal.Rptr.2d 475, 869 P.2d 454
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fStanding alone, a conspiracy does no harm and engenders no tort liability. It must be activated by the commission of an actual tort.\u8221\'3f). Second, a patent-based civil conspiracy claim and a copyright-based civil conspiracy claim both fail as a matter of law because they are both preempted by federal law. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2004231484&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Int\rquote l Rectifier Corp. v. Samsung Elecs. Co.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 361 F.3d 1355, 1361 (Fed. Cir. 2004)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[C]onspiracy to infringe a patent ... has no basis in law.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2029586927&pubNum=0004637&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_4637_618&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_4637_618" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Conceal City, L.L.C. v. Looper Law Enf\rquote t, LLC
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 917 F.Supp.2d 611, 618 (N.D. Tex. 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (collecting cases and holding that \u8220\'3ffederal patent law preempts the civil conspiracy claim of patent infringement.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027851688&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_311&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_311" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Tire Eng\rquote g & Distribution
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 682 F.3d at 311
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[Plaintiff]\rquote s claim for conspiracy to infringe its copyrights is preempted by the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_7903_1188_99}{\*\bkmkend co_pp_sp_7903_1188_99}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1188
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Copyright Act.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040225844&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Benke v. Departure Agency, Inc.
}
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. CV 11-397-VBF(VBKX), 2011 WL 13129964, at *2 (C.D. Cal. Aug. 11, 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (collecting cases and stating \u8220\'3fcourts both within and outside of this Circuit have held that state law civil conspiracy claims based on copyright infringement are preempted by the Copyright Act\u8221\'3f). Nevertheless, because the Court has granted Plaintiff leave to amend its claim for trademark infringement, the Court will also grant Plaintiff leave to amend its civil conspiracy claim. Accordingly, the Court grants Defendants\rquote  motions and dismisses Plaintiff\rquote s civil conspiracy claim without prejudice and with leave to amend.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ice6f2121c88011ea8e45a0b0af345}{\*\bkmkend co_anchor_Ice6f2121c88011ea8e45a0b0af345}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Conclusion
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
For the reasons above, the Court denies Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12(c)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motion for judgment on the pleadings, and the Court grants Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 12
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 motions with partial leave to amend. Specifically, the Court dismisses Plaintiff\rquote s claim for patent infringement with prejudice because the patents-in-suit are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf19 \f2 \i0 \fs20 \chcbpat44 
{\b1 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf25 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for failing to claim patent-eligible subject matter, and the Court dismisses Plaintiff\rquote s trademark claim and its civil conspiracy claim without prejudice and with leave to amend. The Court grants Plaintiff leave to file a second amended complaint within 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
fourteen (14) days
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 from the date this order is filed.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IT IS SO ORDERED.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf20 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_allCitations_99}{\*\bkmkend co_allCitations_99}
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
All Citations
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
258 F.Supp.3d 1170
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \ltrrow \trleft0 
\clpadl200 \clpadfl3 \clbrdrt \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf1 \f4 \i0 \fs20 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Footnotes
\par 
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \ql \li0 \fs20 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00012041948211_99}{\*\bkmkend co_footnote_B00012041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00012041948211_ID0EKRBG_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
1
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Defendants do not move to dismiss or for judgment on the pleadings as to Plaintiff\rquote s claim for copyright infringement.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00022041948211_99}{\*\bkmkend co_footnote_B00022041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00022041948211_ID0ESCAI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
2
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court notes that although Defendants\rquote  motions were filed prior to Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12(c)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 motion, it is appropriate to address the arguments and issues presented in Plaintiff\rquote s motion first because Plaintiff\rquote s motion addresses the threshold issue of whether Defendants can raise the invalidity arguments presented in their 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 motions.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00032041948211_99}{\*\bkmkend co_footnote_B00032041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00032041948211_ID0EQFAI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
3
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court may consider these two license agreements in deciding Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12(c)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 motion because they are documents referenced in and relied on in the pleadings, and no party questions their authenticity. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2011437883&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_763&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_763" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Swartz v. KPMG LLP
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 476 F.3d 756, 763 (9th Cir. 2007)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001385224&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_688&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_688" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Lee v. City of Los Angeles
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 250 F.3d 668, 688 (9th Cir. 2001)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036886962&pubNum=0007903&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_7903_1144&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_7903_1144" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Shame on You Prods., Inc. v. Elizabeth Banks
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 120 F.Supp.3d 1123, 1144 (C.D. Cal. 2015)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00042041948211_99}{\*\bkmkend co_footnote_B00042041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00042041948211_ID0EJGAI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
4
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The agreement defines the term \u8220\'3fPatent Rights\u8221\'3f as \u8220\'3fthe rights of NAI in information, discoveries, concepts, techniques, designs, processes, technology and inventions claimed in the following United States patents, any reissues, reexaminations, or extensions, continuations, continuations-in-part, or divisionals of any of the following United States patents, and any international counterparts to the following United States patents, including the inventions and discoveries described, covered and claimed therein and foreign equivalents identified under Section I at http://www.carnosyn.com/patents.\u8221\'3f (Doc. No. 57\u8211\'3f3, Oparil Decl. Ex. A at Ex. 1 \u182\'3f 2.)
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00052041948211_99}{\*\bkmkend co_footnote_B00052041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00052041948211_ID0EH1AI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
5
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Moreover, the Court rejects Plaintiff\rquote s contention that under Delaware law, a contract should be enforced according to its terms. (Doc. No. 62 at 7.) As Plaintiff acknowledges, Federal Circuit law, not Delaware law, governs the determination of whether a no-contest clause in an agreement bars a party from challenging the validity of a patent. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022953033&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Baseload
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 619 F.3d at 1361
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001114153&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1365&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1365" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Flex\u8211\'3fFoot
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 238 F.3d at 1365. (Doc. No. 62 at 2 n.1.)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00062041948211_99}{\*\bkmkend co_footnote_B00062041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00062041948211_ID0EM4AI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
6
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In its motion, Plaintiff also moves to strike the invalidity arguments contained in Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 motions based on the no-contest clauses in the parties\rquote  agreements. (Doc. No. 57\u8211\'3f1 at 2.) Because the no-contest clauses contained in the relevant agreements are unenforceable, the Court also denies Plaintiff\rquote s motion to strike.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00072041948211_99}{\*\bkmkend co_footnote_B00072041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00072041948211_ID0EOHBI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
7
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Plaintiff also argues that Defendants are precluded from contesting the validity of the patents-in-suit in light of the no-contest clauses contained in the parties\rquote  agreements. (Doc. No. 56 at 11\u8211\'3f12.) But, as explained in ruling on Plaintiff\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12(c)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 motion, the no-contest clauses contained in the relevant agreements are void under 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Lear
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 section II. Accordingly, Defendants are not prohibited from arguing that the patents-in-suit are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00082041948211_99}{\*\bkmkend co_footnote_B00082041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00082041948211_ID0ERVBI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
8
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In its opposition, Plaintiff cites to a district court decision holding that \u8220\'3f[r]arely can a patent infringement suit be dismissed at the pleading stage for lack of patentable subject matter.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038497975&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Bristol\u8211\'3fMyers Squibb Co. v. Merck & Co.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, No. CV 15-560-GMS, 2016 WL 1072841, at *1 (D. Del. Mar. 17, 2016)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (Doc. No. 56 at 15.) The Court does not find Plaintiff\rquote s citation to this district court decision persuasive as it was issued prior to and is contrary to the Federal Circuit\rquote s decision in 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Genetic Techs.
}\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00092041948211_99}{\*\bkmkend co_footnote_B00092041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00092041948211_ID0EHZBI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
9
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In its opposition, Plaintiff asserts that there may be certain claim construction disputes between the parties that would be relevant to the Court\rquote s evaluation of the patents-in-suit\rquote s eligibility under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (Doc. No. 56 at 19\u8211\'3f22.) But, in response, Defendants state that for the purposes of deciding this motion, Defendants will accept Plaintiff\rquote s proposed claim constructions. (Doc. No. 59 at 8.) Accordingly, the Court may decide the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 issues in this case prior to claim construction because there are no claim construction disputes relevant to the eligibility issue. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1373&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1373" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Genetic Techs.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 818 F.3d at 1373
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00102041948211_99}{\*\bkmkend co_footnote_B00102041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00102041948211_ID0E4ACI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
10
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In the FAC, Plaintiff expressly references claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 596 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, and claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (Doc. No. 11, FAC \u182\'3f\u182\'3f 23\u8211\'3f26.) In analyzing the validity of the patents-in-suit under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, Defendants primarily focus on these four specific claims and argue that a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 validity analysis can be performed based on representative claims. (Doc. No. 44\u8211\'3f1 at 10\u8211\'3f11.) In its opposition, Plaintiff does not contest this specific assertion by Defendants or Defendants\rquote  use of representative claims in their 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis, and Plaintiff\rquote s own 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis also focuses on these four specific claims. (
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Doc. No. 56 at 18\u8211\'3f22.) Accordingly, in evaluating the validity of the patents-in-suit under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, the Court will focus on claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 596 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, and claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 as representative claims. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Cf. 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2041877586&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1360&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1360" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Cleveland Clinic
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 859 F.3d at 1360, 2017 WL 2603137, at *5
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3fWhere, as here, the claims \u8216\'3fare substantially similar and linked to the same\u8217\'3f law of nature, analyzing representative claims is proper.\u8221\'3f); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035137097&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_1348&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1348" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Content Extraction & Transmission LLC v. Wells Fargo Bank, Nat. Ass\rquote n
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 776 F.3d 1343, 1348 (Fed. Cir. 2014)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (explaining that the district court \u8220\'3fcorrectly determined that addressing each claim of the asserted patents was unnecessary\u8221\'3f because \u8220\'3fall the claims are \u8216\'3fsubstantially similar and linked to the same abstract idea\u8217\'3f \u8221\'3f and, thus, the district court properly used representative claims in its 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis).
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00112041948211_99}{\*\bkmkend co_footnote_B00112041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00112041948211_ID0E6MCI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
11
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
That beta-alanine is the focus of the claimed invention is also supported by language in the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote s specification. In describing the invention, the specification explains:
\par 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li180 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The invention provides methods of increasing anaerobic working capacity in a tissue, comprising the following steps: (a) providing a beta-alanylhistidine dipeptide and a 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, an 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3c670878475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
insulin
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, an 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3c670878475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
insulin
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 mimic, or an insulin-action modifier; and (b) administering the beta-alanine and at least one of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3c670878475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
insulin
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 mimic, or insulin-action modifier to the tissue in an amount effective to increase beta-alanylhistidine dipeptide synthesis in the tissue, thereby increasing the anaerobic working capacity in the tissue.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 2:45\u8211\'3f53. Here, the specification describes the invention as being directed to providing and administering beta-alanine along with another substance in order to increase the anaerobic working capacity in tissue.
\par 
}
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00122041948211_99}{\*\bkmkend co_footnote_B00122041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00122041948211_ID0EIPCI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
12
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
In light of this, the Court does not find persuasive Plaintiff\rquote s reliance on 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038399831&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Rutgers v. Qiagen N.V.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, No. 15CV7187PGSLHG, 2016 WL 828101 (D.N.J. Feb. 29, 2016)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (Doc. No. 56 at 17.) In that case, the district court found it at least plausible that the claimed invention \u8220\'3fuses artificial conditions that do not occur in nature.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038399831&pubNum=0000999&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Rutgers
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 2016 WL 828101, at *3
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. In contrast, here, the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 provides that beta-alanine occurs naturally within the human body.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00132041948211_99}{\*\bkmkend co_footnote_B00132041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00132041948211_ID0EDZCI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
13
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Plaintiff also argues that when beta-alanine is isolated from the dipeptide, carnosine, beta-alanine has different properties than carnosine. (Doc. No. 56 at 22\u8211\'3f23.) But Plaintiff fails to support this assertion with any citation to the intrinsic record of the patents-in-suit or extrinsic evidence. Further, even assuming Plaintiff is correct, this fact would not alter the Court\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 analysis. In 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Myriad
}\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 }}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, the Supreme Court rejected the argument that the claims at issue were \u8220\'3fsaved by the fact that isolating DNA from the human genome severs chemical bonds and thereby creates a nonnaturally occurring molecule.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_708_2118&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2118" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. Myriad Genetics, Inc.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 569 U.S. 576, 133 S.Ct. 2107, 2118, 186 L.Ed.2d 124 (2013)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_760&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_760" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
In re BRCA1\u8211\'3f & BRCA2\u8211\'3fBased Hereditary Cancer Test Patent Litig.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 774 F.3d 755, 760 (Fed. Cir. 2014)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. Similarly, here, the Court rejects Plaintiff\rquote s contention that isolating beta-alanine from carnosine is sufficient to render the claims subject matter eligible and not directed to a natural phenomenon.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00142041948211_99}{\*\bkmkend co_footnote_B00142041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00142041948211_ID0EKIDI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
14
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court notes that while the Court addresses and rejects Plaintiff\rquote s preemption argument in its analysis of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, the Court\rquote s analysis and rejection of this particular argument applies equally to the other patents-in-suit.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00152041948211_99}{\*\bkmkend co_footnote_B00152041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00152041948211_ID0EJNDI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
15
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court notes that claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is similar to claim 1 of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, except that claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 also includes creatine in the dietary supplement. Accordingly, the Court\rquote s analysis as to the eligibility of claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 also applies to its analysis of claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00162041948211_99}{\*\bkmkend co_footnote_B00162041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00162041948211_ID0EDZDI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
16
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court notes that claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is similar to claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 except that the dietary supplement claimed in claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 contains a mixture of beta-alanine and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, rather than beta-alanine, creatine, and a carbohydrate. Accordingly, the Court\rquote s analysis as to the eligibility of claim 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024992036&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I9f0d4b1a662011e0af6af9916f973d19&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 084 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 and claim 34 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038574449&pubNum=0004073&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I578d0720f75111e5b10ddcfb6b98f38d&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 947 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 also applies to its analysis of claim 6 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00172041948211_99}{\*\bkmkend co_footnote_B00172041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00172041948211_ID0EM1DI_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
17
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Plaintiff argues that the term \u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u8221\'3f in claim 6 should be construed to include 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 from other sources, i.e., non-natural sources. (Doc. No. 56 at 20 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018374372&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I12e6e07a132211deb7e683ba170699a5&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 376 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 6:8-11).) But even assuming Plaintiff is correct, and the term \u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u8221\'3f in claim 6 encompasses both non-natural and natural 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, that would still mean that natural 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, a naturally occurring phenomenon, would be included with the scope of claim 6. Further, as Defendants correctly note, Plaintiff has failed to identify any meaningful difference between 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 derived from other sources and natural 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (Doc. No. 59 at 9.) In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=RP&fi=co_pp_sp_506_760&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_760" }{\fldrslt 
{\b0 \cf25 \f4 \i0 \fs18 
{\b0 \cf25 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
In re BRCA1\u8211\'3f & BRCA2\u8211\'3fBased Hereditary Cancer Test Patent Litig.
}
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 774 F.3d 755, 760 (Fed. Cir. 2014)
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, the Federal Circuit held that claims directed to DNA primers were ineligible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \i0 \fs18 \chcbpat44 
{\b1 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf25 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 even though the primers \u8220\'3fare synthetically replicated\u8221\'3f because the primers \u8220\'3fare structurally identical to the ends of DNA strands found in nature.\u8221\'3f Thus, without Plaintiff identifying some meaningful difference between natural 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 and synthetic 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, the fact that the claimed 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=Iffb483c06c7111e18b05fdf15589d8e8&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
glycine
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 might be derived from other sources is insufficient to render claim 6 patent eligible.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrb \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00182041948211_99}{\*\bkmkend co_footnote_B00182041948211_99}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00182041948211_ID0ERIAK_99" }{\fldrslt 
{\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
18
}\super \b0 \cf25 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
This law of nature is disclosed in the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 596 patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. 
}
{\b0 \cf1 \f4 \i0 \fs18 
{\b0 \cf1 \f4 \ul1 \strike0 \i0 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999385326&pubNum=0004074&originatingDoc=Ieaecbd305b0f11e7bcf2cc0f37ee205d&refType=PA&docFamilyGuid=I5911c3e072e611d7a07084608af77b15&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 596 Patent
}\b0 \cf25 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 2:10\u8211\'3f13, 4:58\u8211\'3f5:26.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \lastrow \trleft0 
\clpadt24 \clpadft3 \clpadl100 \clpadfl3 \clpadr24 \clpadfr3 \clbrdrt \brdrcf21 \brdrw10 \brdrs \clbrdrb \clbrdrl \trql \clvertalt \clwWidth4320 \cellx4320 
\clpadt29 \clpadft3 \clpadl100 \clpadfl3 \clpadr29 \clpadfr3 \clbrdrt \brdrcf21 \brdrw10 \brdrs \clbrdrb \clbrdrr \trql \clvertalt \clwWidth5760 \cellx10080 
\intbl 
{\ri24 \li24 
{\b1 \cf21 \f4 \ri24 \i0 \ql \fs16 \li24 
{\b1 \cf21 \f4 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
End of Document
\par 
}
}
}\b1 \cf21 \f4 \ri24 \ul0 \strike0 \i0 \ql \li24 \fs16 \sa0 \sb0 \intbl \cell \intbl 
{\ri29 \li29 
{\qr \b0 \cf21 \f4 \ri29 \i0 \fs19 \li29 
{\b0 \cf21 \f4 \ul0 \strike0 \i0 \fs19 \sa0 \sb0 
\u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
\par 
}
}
}\qr \b0 \cf21 \f4 \ri29 \ul0 \strike0 \i0 \li29 \fs19 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}\sect }